UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 30, 2003
BIOANALYTICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
| Indiana | 0-23357 | 35-1345024 |
|
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) | (IRS Employer Identification No.) |
|
2701 Kent Avenue West Lafayette, IN |
47906-1382 | |
| (Address of principal executive offices) | (Zip Code) | |
| (765) 463-4527 | ||
| (Registrant's telephone number, including area code) |
Item 5.
On July 1, 2003, Bioanalytical Systems, Inc. (the "Company") issued the press release filed herewith as Exhibit 99.1, and incorporated herein by reference, announcing the completion of its acquisition of PharmaKinetics Laboratories, Inc.
Item 7. Financial Statements and Exhibits.
The following exhibits are filed as a part of this report:
(c) Exhibits
99.1 Press release, dated July 1, 2003, announcing the completion its acquisition of PharmaKinetics Laboratories, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: July 1, 2003 |
BIOANALYTICAL SYSTEMS, INC. (Registrant) By: /s/ Douglas P. Wieten Douglas P. Wieten Vice President - Finance, Chief Financial Officer and Treasurer |
Exhibit Index
|
Item Number assigned in Regulation S-K |
Exhibit | Description of Exhibits |
|---|
99 |
(99.1) |
Press release dated July 1, 2003. |